Pasithea Capital Expenditures vs Free Cash Flow Analysis

KTTA Stock  USD 2.73  0.06  2.15%   
Pasithea Therapeutics financial indicator trend analysis is much more than just breaking down Pasithea Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pasithea Therapeutics is a good investment. Please check the relationship between Pasithea Therapeutics Capital Expenditures and its Free Cash Flow accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pasithea Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Capital Expenditures vs Free Cash Flow

JavaScript chart by amCharts 3.21.15201420162018202020222024200K400K600K800K1M1.2M1.4M1.6M1.8M2M2.2M -17M-16M-15M-14M-13M-12M-11M-10M-9M-8M-7M-6M-5M-4M-3M-2M-1M
JavaScript chart by amCharts 3.21.15Capital Expenditurestotal: 2.3MFree Cash Flowtotal: -46.5M

Capital Expenditures vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pasithea Therapeutics Capital Expenditures account and Free Cash Flow. At this time, the significance of the direction appears to have strong contrarian relationship.
Capital ExpendituresFree Cash FlowDiversified AwayCapital ExpendituresFree Cash FlowDiversified Away100%
The correlation between Pasithea Therapeutics' Capital Expenditures and Free Cash Flow is -0.63. Overlapping area represents the amount of variation of Capital Expenditures that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Pasithea Therapeutics Corp, assuming nothing else is changed. The correlation between historical values of Pasithea Therapeutics' Capital Expenditures and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Expenditures of Pasithea Therapeutics Corp are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Capital Expenditures i.e., Pasithea Therapeutics' Capital Expenditures and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.63
Relationship DirectionNegative 
Relationship StrengthWeak

Capital Expenditures

Capital Expenditures are funds used by Pasithea Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Pasithea Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
Most indicators from Pasithea Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pasithea Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pasithea Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
At present, Pasithea Therapeutics' Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 31 M, whereas Sales General And Administrative To Revenue is forecasted to decline to 16.32.
 2010 2022 2023 2024 (projected)
Reconciled Depreciation1.4K32.4K517.7K543.5K
Cost Of Revenue17.3K113.2K648.5K680.9K

Pasithea Therapeutics fundamental ratios Correlations

0.530.71.00.93-0.96-0.630.680.980.980.940.860.950.911.00.99-0.250.98-0.25-0.42-0.420.6-0.42-0.42-0.42-0.42
0.530.80.520.8-0.35-0.940.940.460.460.740.470.70.730.520.46-0.950.43-0.95-0.94-0.990.18-0.94-0.99-0.99-0.99
0.70.80.680.88-0.54-0.940.920.570.570.90.80.890.930.680.58-0.660.55-0.66-0.62-0.770.66-0.62-0.76-0.74-0.76
1.00.520.680.92-0.97-0.610.670.990.990.930.850.940.91.00.99-0.230.98-0.23-0.41-0.40.59-0.41-0.4-0.41-0.4
0.930.80.880.92-0.81-0.870.90.870.870.990.840.980.980.920.87-0.580.85-0.58-0.69-0.720.56-0.69-0.72-0.72-0.72
-0.96-0.35-0.54-0.97-0.810.42-0.48-0.99-0.99-0.83-0.74-0.86-0.8-0.97-0.980.05-0.990.050.210.22-0.480.210.220.220.22
-0.63-0.94-0.94-0.61-0.870.42-1.0-0.51-0.51-0.85-0.7-0.81-0.86-0.61-0.520.85-0.480.850.860.92-0.510.860.920.910.92
0.680.940.920.670.9-0.48-1.00.580.580.880.730.840.880.670.58-0.830.55-0.83-0.87-0.910.5-0.87-0.91-0.91-0.91
0.980.460.570.990.87-0.99-0.510.581.00.870.770.890.830.991.0-0.161.0-0.16-0.36-0.330.48-0.36-0.33-0.34-0.33
0.980.460.570.990.87-0.99-0.510.581.00.870.770.890.830.991.0-0.161.0-0.16-0.36-0.330.48-0.36-0.33-0.34-0.33
0.940.740.90.930.99-0.83-0.850.880.870.870.91.00.990.930.88-0.50.86-0.5-0.6-0.650.66-0.6-0.65-0.65-0.65
0.860.470.80.850.84-0.74-0.70.730.770.770.90.890.90.850.78-0.220.76-0.22-0.38-0.380.91-0.38-0.38-0.39-0.38
0.950.70.890.940.98-0.86-0.810.840.890.891.00.890.990.940.89-0.460.87-0.46-0.55-0.610.65-0.55-0.61-0.6-0.61
0.910.730.930.90.98-0.8-0.860.880.830.830.990.90.990.90.84-0.50.81-0.5-0.57-0.660.68-0.57-0.65-0.64-0.65
1.00.520.681.00.92-0.97-0.610.670.990.990.930.850.940.90.99-0.230.98-0.23-0.41-0.40.59-0.41-0.4-0.41-0.4
0.990.460.580.990.87-0.98-0.520.581.01.00.880.780.890.840.99-0.161.0-0.16-0.36-0.330.49-0.36-0.33-0.34-0.33
-0.25-0.95-0.66-0.23-0.580.050.85-0.83-0.16-0.16-0.5-0.22-0.46-0.5-0.23-0.16-0.131.00.930.980.010.930.980.980.98
0.980.430.550.980.85-0.99-0.480.551.01.00.860.760.870.810.981.0-0.13-0.13-0.34-0.30.47-0.34-0.3-0.31-0.3
-0.25-0.95-0.66-0.23-0.580.050.85-0.83-0.16-0.16-0.5-0.22-0.46-0.5-0.23-0.161.0-0.130.930.980.010.930.980.980.98
-0.42-0.94-0.62-0.41-0.690.210.86-0.87-0.36-0.36-0.6-0.38-0.55-0.57-0.41-0.360.93-0.340.930.93-0.121.00.940.960.94
-0.42-0.99-0.77-0.4-0.720.220.92-0.91-0.33-0.33-0.65-0.38-0.61-0.66-0.4-0.330.98-0.30.980.93-0.130.931.01.01.0
0.60.180.660.590.56-0.48-0.510.50.480.480.660.910.650.680.590.490.010.470.01-0.12-0.13-0.12-0.13-0.13-0.13
-0.42-0.94-0.62-0.41-0.690.210.86-0.87-0.36-0.36-0.6-0.38-0.55-0.57-0.41-0.360.93-0.340.931.00.93-0.120.940.960.94
-0.42-0.99-0.76-0.4-0.720.220.92-0.91-0.33-0.33-0.65-0.38-0.61-0.65-0.4-0.330.98-0.30.980.941.0-0.130.941.01.0
-0.42-0.99-0.74-0.41-0.720.220.91-0.91-0.34-0.34-0.65-0.39-0.6-0.64-0.41-0.340.98-0.310.980.961.0-0.130.961.01.0
-0.42-0.99-0.76-0.4-0.720.220.92-0.91-0.33-0.33-0.65-0.38-0.61-0.65-0.4-0.330.98-0.30.980.941.0-0.130.941.01.0
Click cells to compare fundamentals

Pasithea Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Pasithea Therapeutics is a strong investment it is important to analyze Pasithea Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pasithea Therapeutics' future performance. For an informed investment choice regarding Pasithea Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pasithea Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pasithea Therapeutics. If investors know Pasithea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pasithea Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(14.79)
Revenue Per Share
0.37
Quarterly Revenue Growth
14.981
Return On Assets
(0.38)
Return On Equity
(0.63)
The market value of Pasithea Therapeutics is measured differently than its book value, which is the value of Pasithea that is recorded on the company's balance sheet. Investors also form their own opinion of Pasithea Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Pasithea Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pasithea Therapeutics' market value can be influenced by many factors that don't directly affect Pasithea Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pasithea Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pasithea Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pasithea Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
News Freq…Investor S…